QSS
AMED

Quantitative Systematic Strategies’s Amedisys AMED Stock Holding History

Quantitative Systematic Strategies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,404
Closed -$2.07M – 258
2019
Q4 		$2.07M Buy
12,404
+2,578
+26% +$383K 0.3% 104
2019
Q3 		$1.29M Buy
9,826
+1,554
+19% +$202K 0.3% 105
2019
Q2 		$1M Buy
8,272
+6,645
+408% +$789K 0.19% 153
2019
Q1 		$201K Sell
1,627
-5,725
-78% -$719K 0.05% 330
2018
Q4 		$861K Sell
7,352
-1,140
-13% -$134K 0.19% 163
2018
Q3 		$1.06M Buy
8,492
+5,955
+235% +$658K 0.2% 170
2018
Q2 		$217K Buy
+2,537
New +$186K 0.04% 542
2018
Q1 		– Sell
-4,384
Closed -$231K – 616
2017
Q4 		$231K Buy
4,384
+719
+20% +$37.9K 0.06% 464
2017
Q3 		$205K Buy
+3,665
New +$194K 0.05% 399

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Quantitative Systematic Strategies's AMED Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of Amedisys (AMED) in Q1 2020, closing a stake of 12,404 shares — an estimated $2.07M sold.

Quantitative Systematic Strategies first reported a position in AMED in Q3 2017 and held it in 9 quarters. The position peaked at $2.07M in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Quantitative Systematic Strategies reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 12,404 Amedisys shares in Q1 2020, an estimated $2.07M.
  • Quantitative Systematic Strategies first reported a position in Amedisys in Q3 2017 and held it in 9 quarters.
  • Quantitative Systematic Strategies's Amedisys position peaked at $2.07M in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.